Patents
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
08/2011
08/03/2011EP2349266A1 Sulfonamide containing compounds and uses thereof
08/03/2011EP2349256A1 Heterocyclic benzimidazoles as trpm8 modulators
08/03/2011EP2348846A1 Disubstituted azepan orexin receptor antagonists
08/03/2011EP2240458B1 Aryl sulfonamides as effective analgesics
08/03/2011EP2155690B1 Indazolamide derivatives
08/03/2011EP2152674B1 Benzimidazolone chymase inhibitors
08/03/2011EP1794146B1 Tricyclic anilide spirohydantoin cgrp receptor antagonists
08/03/2011CN1964970B Iap的抑制剂 Iap inhibitors
08/03/2011CN1890218B Tubulin inhibitors
08/03/2011CN102143959A Hepatitis c virus inhibitors
08/03/2011CN102143958A Pyridazine derivatives as SMO inhibitors
08/03/2011CN102143957A Benzimidazoles and related analogs as sirtuin modulators
08/03/2011CN102140090A Dipeptidyl peptidase inhibitors
08/03/2011CN101410381B Novel 2-substituted benzimidazoles as selective androgen receptor modulators (SARMs)
08/03/2011CN101119973B 2-(phenyl or heterocyclic)-1h-phenantrho[9,10-d]imidazoles as mpges-1 inhibitors
08/02/2011US7990046 Material for organic electroluminescent devices and organic electroluminescent devices made by using the same
08/02/2011US7989634 Melanocortin receptor agonists
08/02/2011US7989626 Modulators of cellular adhesion
08/02/2011US7989622 Phosphatidylinositol 3-kinase inhibitors and methods of their use
08/02/2011US7989620 Hydantoin derivatives for the treatment of obstructive airway diseases
08/02/2011US7989485 Imidazole compounds having pharmaceutical activity towards the sigma receptor
08/02/2011US7989475 Substituted pyrazoles, compositions containing such compounds and methods of use
08/02/2011US7989462 4-arylamin-or-4-heteroarylamino-quinazolines and analogs as activators of caspases and inducers of apoptosis and the use thereof
08/02/2011US7989460 Quinazoline derivatives as angiogenesis inhibitors
08/02/2011US7989458 Pyrimidine derivatives as alk-5 inhibitors
08/02/2011CA2471577C Chemical compounds
08/02/2011CA2463709C N-substituted pyrrolidin derivatives as dipeptidyl peptidase iv inhibitors
08/02/2011CA2447010C Substituted 4h-chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof
07/2011
07/28/2011WO2011090911A1 Amino heteroaryl compounds as beta-secretase modulators and methods of use
07/28/2011WO2011090738A2 Type ii raf kinase inhibitors
07/28/2011WO2011089614A1 PROCESS FOR PREPARING ELETRIPTAN HYDROBROMIDE HAVING α-FORM
07/28/2011WO2011088877A1 Compounds for electronic devices
07/28/2011WO2011022596A3 Preparation of bazedoxifene and its salts
07/28/2011US20110184187 Process for the preparation of tetrazole derivatives from organo boron and organo aluminium azides
07/28/2011US20110184166 Geometric synthesis of porphyrin rods
07/28/2011US20110183995 Eltoprazine for suppression of l-dopa induced dyskinesias
07/28/2011US20110183994 Polymorphic forms of 1-'4-(5-cyanoindol-3-yl) butyl-4-(2-carbamoylbenzofuran-5-yl) piperazine hydrochloride
07/28/2011US20110183991 5ht7 receptor ligands and compositions comprising the same
07/28/2011US20110183986 Polycyclic aryl substituted triazoles and polycyclic heteroaryl substituted triazoles useful as axl inhibitors
07/28/2011US20110183980 O-benzyl nicotinamide analogs as mglur5 positive allosteric modulators
07/28/2011US20110183977 Benzene, pyridine, and pyridazine derivatives
07/28/2011US20110183961 Azetidine polysubstituted compounds, preparation thereof, and therapeutic application thereof
07/28/2011US20110183958 Azetidine derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
07/28/2011US20110183957 Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
07/28/2011US20110183955 2-Aminocarbonyl Substituted Piperazine or Diaza-Cyclic Compounds as Apoptosis Protein Inhibitors (Iap) Modulators
07/28/2011US20110183952 New chemical compounds
07/28/2011US20110183915 Small Molecule Cancer Treatments that cause Necrosis in Cancer Cells but do not Affect Normal Cells
07/28/2011US20110182850 Organic compounds and their uses
07/28/2011DE102010005697A1 Verbindungen für elektronische Vorrichtungen Compounds for electronic devices
07/28/2011CA2788363A1 Amino heteroaryl compounds as beta-secretase modulators and methods of use
07/28/2011CA2784807A1 Type ii raf kinase inhibitors
07/28/2011CA2783624A1 Heteroaryl compounds and uses thereof
07/27/2011EP2348019A1 1,2-diazetidin-3-one derivative and pharmaceutical agent comprising same
07/27/2011EP2346859A1 Heterocyclic jak kinase inhibitors
07/27/2011EP2346858A2 Methods for preparing oxazolidinones and compositions containing them
07/27/2011EP2346857A2 Compounds for the treatment of inflammatory disorders
07/27/2011EP2346856A1 2-[1h-benzimidazol-2(3h)-ylidene]-2-(pyrimidin-2-yl)acetamides and 2-[benzothiazol-2(3h)-ylidene]-2-(pyrimidin-2-yl)acetamides as kinase inhibitors
07/27/2011EP2346852A1 Pyrrolidin-2-ones as hdm2 ligands
07/27/2011EP2346849A1 Piperazine compounds with herbicidal effect
07/27/2011EP2346830A1 Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
07/27/2011EP2346824A1 Novel estrogen receptor ligands
07/27/2011EP2346821A1 Sphingosine-1-phosphate receptor antagonists
07/27/2011EP2099769B1 6-oxo.-1, 6-dihydropyrimidin-2-yls in the treatment of proliferative diseases
07/27/2011EP2061762B1 Pyrazine compounds, their use and methods of preparation
07/27/2011EP2016073B1 Process for the preparation of pure irbesartan
07/27/2011EP1948617B1 Pyrimidinones as casein kinase ii (ck2) modulators
07/27/2011EP1945626B1 Imidazole derivatives as functionally selective alpha2c adrenoreceptor agonists
07/27/2011EP1753746B1 Novel pyrrole derivatives with angiotensin ii antagonist activity
07/27/2011EP1641764B1 5-membered heterocycle-based p38 kinase inhibitors
07/27/2011EP1638568B1 Indole, azaindole and related heterocyclic n-substituted piperazine derivatives
07/27/2011EP1490355B1 Indolylmaleimide derivatives
07/27/2011EP1419152B1 Hiv inhibiting pyrimidines derivatives
07/27/2011CN102137858A 5-lipoxygenase-activating protein inhibitor
07/27/2011CN102137857A Processes for the preparation of benzoimidazol-2-yl pyrimidine derivatives
07/27/2011CN102137848A 2,4-diaminopyrimidine compound
07/27/2011CN102137847A Bicyclic heterocycles as MEK kinase inhibitors
07/27/2011CN102137842A Preparation of 3-pyrrole substituted 2-indolinone derivatives
07/27/2011CN102134235A Preparation method of 2-oxo-1-pyrrolidine derivative
07/27/2011CN102134234A Indazolyl urea compounds and preparation method and medicinal use thereof
07/27/2011CN102134231A Dipeptidyl peptidase inhibitors
07/27/2011CN102134230A Dipeptidyl peptidase inhibitors
07/27/2011CN102134229A Dipeptidyl peptidase inhibitors
07/27/2011CN102134214A Isoindolone compounds and their use as metabotropic glutamate receptor potentiators
07/26/2011US7985771 Furanone derivatives
07/26/2011US7985765 Therapeutic substituted pyrroles
07/26/2011US7985730 3-aminopyrrolidine derivatives as modulators of chemokine receptors
07/26/2011CA2603185C Propane-1,3-dione derivative or salt thereof
07/26/2011CA2508412C Pesticidal 5-(acylamino) pyrazole derivatives
07/26/2011CA2487976C Calcitonin gene related peptide receptor antagonists
07/26/2011CA2464333C Heteroindanes: a new class of potent cannabimimetic ligands
07/26/2011CA2463615C Oxindole hydrazide modulators of protein tyrosine phosphatases (ptps)
07/26/2011CA2445344C Heterocyclic compound derivatives and medicines
07/26/2011CA2427655C Use of alpha adrenergic receptor agonist to reduce a decrease in neurosensory retinal function following laser therapy for choroidal neovascularization
07/21/2011WO2011086955A1 Process for preparation of pyrimidinylpyrazole compounds
07/21/2011WO2011086099A1 Novel substituted triazole derivatives as gamma secretase modulators
07/21/2011WO2011086031A1 Methods for the preparation of indazole-3-carboxyclic acid and n-(s)-1-azabicyclo[2.2.2]oct-3-yl-1h-indazole-3-carboxamide hydrochloride salt
07/21/2011WO2011085886A1 Pyrrolidine derivatives
07/21/2011WO2011085781A1 Materials for organic electroluminescent devices
07/21/2011WO2011085532A1 Conjugated chain beta-n-substituted pentamethine cyanine fluorescent dye
07/21/2011WO2011028044A3 Pyrazole derivatives, preparation method thereof, and composition for prevention and treatment of osteoporosis containing same